higher frequencies of K-ras gene mutations (8). Various studies Glutathione S-transferase µ1 (GSTM1) plays a role in have shown that chemical carcinogens can selectively induce the detoxification of benzo[a]pyrene (BP) diol epoxide in specific base pair changes found in codons 12, 13 and 61 of tobacco smoke. Individuals who genetically lack the GSTM1 the K-ras gene (9-11). It has, therefore, been speculated that gene are likely to have an increased risk of smoking-related there may be a correlation among GSTM1 genotype, K-ras lung cancers, however, the target oncogenes for mutation gene mutation and smoking. The purpose of this study was to are unknown. To investigate the relation between GSTM1 investigate the possible relation between the GSTM1 null genotype and K-ras gene mutation we examined 193 genotype and K-ras gene mutation in human non-small cell adenocarcinomas and 119 squamous cell carcinomas of lung cancer.
lung. The GSTM1 genotype was determined by PCR and
We studied 312 lung tumors from 312 patients who under-K-ras gene mutations at codons 12 and 13 were detected went surgical resection for primary non-small cell lung by dot-blot hybridization analysis using sequence-specific carcinoma between 1986 and 1996 at the Second Department oligonucleotide probes. K-ras gene mutations were found of Surgery of Fukuoka University Hospital. The tumors in 29 of 312 (9.3%) tumors. All of them arose in patients included 193 adenocarcinomas and 119 squamous cell carcinwho were habitual smokers. Mutations of the K-ras gene omas. In adenocarcinoma patients the mean age was 63.8 were detected in 6 of 100 (6%) and 15 of 93 (16.1%) years and the group was made up of 115 men and 78 women. adenocarcinoma cases with the GSTM1(⍣) and GSTM1(-)
In squamous cell carcinoma patients the mean age was 68.4 genotypes, respectively, and the difference was statistically years and the group was made up of 101 men and 18 women. significant. These findings suggest that the cause of K-ras Information about smoking habits was obtained from the gene mutation in smokers with lung adenocarcinoma may hospital patient records. The patients were classified as be in part an accumulation of BP diol epoxide which is smokers and non-smokers. Smokers included patients who not well detoxified in individuals with the GSTM1 null were former smokers. Non-smokers were patients who had genotype. never smoked. DNA was isolated from frozen tissue and blood using standard procedures with proteinase K and phenol/ chloroform extraction. Tobacco smoke contains several carcinogens, including
The GSTM1 genotypes were at first determined using DNAs benzo[a]pyrene (BP) and other polycyclic aromatic hydrofrom peripheral granulocytes and carcinoma tissues in 100 of carbons (PAHs) that initiate cancer. Many of these carcinogens the 312 lung carcinoma patients. We could obtain neither a are oxidized by phase I enzymes into reactive metabolites that blood sample nor normal tissue from the rest of the 212 are detoxified by phase II enzymes. Glutathione S-transferases patients. The GSTM1 genotype of peripheral granulocytes was (GSTs), important phase II enzymes, play a major role in the in complete agreement with that of the carcinoma tissue in cellular detoxification of carcinogens and protect DNA against each subject and somatic mutation of the GSTM1 gene is not damage. The glutathione S-transferase µ1 (GSTM1) gene locus known to occur in lung carcinoma. Therefore, the GSTM1 is polymorphic owing to a gene deletion, which results in the genotyping study was performed using tumor tissue in the virtual absence of GSTµ enzyme activity in individuals with remaining 212 carcinoma patients. Furthermore, we determined both alleles deleted [GSTM1(-)]; approximately half of the the GSTM1 genotype in 138 healthy Japanese controls using population in various ethnic groups are of GSTM1 null genotype DNA from peripheral granulocytes. The GSTM1 genotyping (1). The GSTM1 gene product is suggested to be particularly was carried out by PCR according to the method of Comstock important for detoxifying BP diol epoxide (2); individuals et al. (12) . The GSTM1 genotype was determined by the genetically lacking GSTM1 activity can potentially be at an presence or absence of PCR product. Primers MFD65-L enhanced risk for smoking-related lung cancer. Many studies (GCAAACCACAATGGAATGCA) and MFD65-R (CTTTshow that lack of GSTM1 activity or of its gene is responsible ACTTCCTTTGCCTCAG), which amplify a 154-170 bp CA repeat marker on chromosome arm 16q, were used as internal controls (D16S267; 13) (1). If PCR products were faint assays GSTM1, glutathione S-transferase µ1; PAHs, polycyclic aromatic hydrocarbons; SSOPs, sequence-specific oligonucleotide probes.
were repeated with a sample diluted 5-fold with deionized water. All assays were done in duplicate and the concordance codons 12 and 13 of the K-ras gene were 5Ј-GCCTGCTGAAb Wild-type GGC (Gly).
AATGACTGAAT-3Ј (sense) and 5Ј-CGTCCACAACCTGA-TTCTGAAT-3Ј (antisense). Amplification conditions were an initial cycle at 95°C for 5 min followed by 30 cycles of 95°C mM EDTA, pH 8.0, 5ϫ Denhart's solution, 0.1% SDS and 100 µg/ml heat-denatured herring sperm DNA. After hybridization with labeled SSOPs at 54°C for 1 h the filters were washed the GSTM1 genotype and smoking in the patients; GSTM1(-) was found in 51.3 and 51.2% of habitual smokers and nontwice for 5 min at room temperature in 2ϫ SSPE and 0.1% SDS with constant gentle agitation, once for 10 min at room smokers, respectively. Using the PCR SSOP hybridization assay K-ras gene temperature in TMAC solution (50 mM Tris-HCl, pH 8.0, 3.0 M tetramethylammonium chloride, 2 mM EDTA, pH 8.0, and mutations were detected in 29 of 312 (9.3%) lung cancer specimens (Table I) . Mutations were found in 21 of 193 0.1% SDS), twice for 15 min at 59°C in the TMAC solution and once for 5 min at room temperature in 2ϫ SSPE. After (10.9%) adenocarcinomas and in 8 of 119 (6.7%) squamous cell carcinomas. All patients having tumors with a K-ras removing excess fluid on Wattmann 3MM filters the filters were exposed to Kodak XAR5 film for 2 h at room temperature mutation were smokers. K-ras mutations were significantly more frequent in male patients, 26 of 216 (12%), than in to obtain hybridization signals.
The statistical significance of each finding was determined female patients, 3 of 96 (3.1%) (P ϭ 0.010). However, when we compared the K-ras mutation rates in the patients with using Fisher's direct probability test or the Kruskal-Wallis test. The odds ratio and 95% confidence interval were estimated smoking history there was no significant gender difference; 26 of 205 (12.7%) smoking male patients and 3 of 25 (12%) by logistic regression analysis. Differences with a P value Ͻ0.05 were considered significant. smoking female patients. We first analyzed the association between GSTM1 genotype The GSTM1 genotype was determined by the detection of at least one GSTM1 gene [GSTM1(ϩ)] or its homozygous and K-ras gene mutation in all patients. Mutations of the K-ras gene were found in 9 of 152 (5.9%) patients with the deletion [GSTM1(-)]. Although loss of heterozygosity at chromosome 1p has since been described in~15-18% of GSTM1(ϩ) genotype and in 20 of 160 (12.5%) with the GSTM1(-) genotype. K-ras gene mutation was significantly non-small cell lung cancers (14,15) there is little possibility of mistyping the GSTM1 genotype in tumor tissue due to loss more frequent in GSTM1(-) than in GSTM1(ϩ) carriers (P ϭ 0.045). When we investigated this association by taking into of heterozygosity at 1p32, because the GSTM1 genotype of peripheral granulocytes was in complete agreement with that account the histological type of lung tumors, GSTM1 genotype and K-ras gene mutation were significantly associated in of the carcinoma tissue in our 100 patients and somatic mutation of the GSTM1 gene is not known to occur in lung adenocarcinoma (P ϭ 0.024) but not in squamous cell carcinoma (Table II) . carcinoma. However, the possibility of GSTM1 mistyping in 212 patients cannot be completely disproved. Among the 138
The K-ras gene is mutated in~20-30% of non-small cell lung cancers in Europeans and Americans (5,16), while the healthy Japanese controls 66 (47.8%) and 72 (52.2%) were identified as GSTM1(ϩ) and GSTM1(-), respectively. Among frequency in Japanese is 6.9-12% (17,18); our results are consistent with the reported frequency in Japanese. K-ras gene the 312 patients with lung carcinoma 152 (48.7%) and 160 (51.3%) were GSTM1(ϩ) and GSTM1(-), respectively. The mutations were found more frequently in adenocarcinoma than in squamous cell carcinoma in this study, as has been reported frequency of the GSTM1 null genotype, GSTM1(-), did not differ significantly between the healthy controls and patients.
(3,16-19). K-ras mutations are more frequently detected in adenocarcinomas obtained from patients who were habitual There was no significant difference in the GSTM1 genotype among the patients classified by histological tumor type or smokers than in those from patients who never smoked. The association between smoking and the development of mutations sex. In addition, there was no significant correlation between GSTM1 genotype and K-ras mutation in lung cancer in the K-ras gene suggests that carcinogenic agents in tobacco References smoke may induce these mutations. G→T transversions (24, 25) . GSTM1 genotype was found to carcinoma is related to smoking, however, there was no relation D16S267 loci. Nucleic Acids Res., 18, 4034. 14. Tsuchiya,E., Nakamura,Y., Weng,S.Y., Nakagawa,K., Tsuchiya,S., between the GSTM1(-) genotype and K-ras gene mutation in smoking-associated p53 gene mutations. They also examined
